Cancer Commons News and Events

Head for the Cure logo, Musella Foundation For Brain Tumor Research & Information logo, and Cancer Commons logo

Press Release: Brain Cancer Support and Solutions Alliance Launches Dedicated Nurse Navigator for Comprehensive Patient and Caregiver Assistance

September 26, 2024

FOR IMMEDIATE RELEASE: KANSAS CITY, MO; HEWLETT, NY; and PALO ALTO, CA, September 26, 2024 /PRNewswire.com/ — The Brain Cancer Support and Solutions Alliance (BCSSA), a collaboration between nonprofits Head for the Cure, the Musella Foundation, and Cancer Commons, proudly announces the appointment of a dedicated Neuro-Oncology Nurse Navigator, now actively providing critical support for brain cancer patients and their caregivers. The newly established… Read more »

Head for the Cure, Musella Foundation For Brain Tumor Research & Information, and Cancer Commons launch Brain Cancer Support and Solutions Alliance

Press Release: Brain Cancer Support and Solutions Alliance Launched to Improve Care and Outcomes for Brain Tumor Patients

May 31, 2024

FOR IMMEDIATE RELEASE: KANSAS CITY, Mo., and HEWLETT, N.Y., and PALO ALTO, Calif., May 31, 2024 /PRNewswire/ — Head for the Cure, the Musella Foundation For Brain Tumor Research & Information, and Cancer Commons today announced the launch of the Brain Cancer Support and Solutions Alliance to provide support, education, and guidance to brain cancer patients and their caregivers. Brain tumors present unique challenges, demanding specialized care from diagnosis through… Read more »

Curious Dr. George logo, Cancer Commons logo, and photo of Thomas N. Seyfried, PhD, Professor of Biology at Boston College

NEW Curious Dr. George—Treating Pancreatic Cancer: Could Metabolism—Not Genomics—Be the Key?

April 2, 2024

Here’s the latest from our Curious Dr. George! Read “Treating Pancreatic Cancer: Could Metabolism—Not Genomics—Be the Key?” here. In 2018, we published a Curious Dr. George post featuring Thomas N. Seyfried, PhD, about cancer possibly being mostly a metabolic—rather than genetic—disease. Since then, the field of cancer genomics has expanded enormously, and we have published many posts in support of better understanding and treatment of many types… Read more »

Curious Dr. George logo, Cancer Commons logo, and photo of Anthony M. Magliocco, MD, Founder & CEO, Protean BioDiagnostics

Curious Dr. George—Protean BioDiagnostics: One Way to Access Full-Service Precision Oncology Testing

March 12, 2024

Here’s the latest from our Curious Dr. George! Read “Protean BioDiagnostics: One Way to Access Full-Service Precision Oncology Testing” here. The use of advanced molecular testing of various cancers over the last 10-15 years has driven development of the field of precision oncology. Now, many patients with a variety of cancer types can benefit from targeted therapies. However, accessing precision testing and treatment can… Read more »

Curious Dr. George logo, Cancer Commons logo, and photo of David J. Einstein, MD, Assistant Professor of Medicine, Harvard Medical School & Genitourinary Oncologist, Beth Israel Deaconess Medical Center

Curious Dr. George—How a Harvard Oncologist Would Manage His Own Metastatic Kidney Cancer

March 5, 2024

Here’s the latest from our Curious Dr. George! Read “How Would a Harvard Oncologist Manage His Own Metastatic Kidney Cancer?” here. When facing a frightening new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks kidney cancer expert David J. Einstein, MD, how he would handle his own hypothetical case of kidney… Read more »

Curious Dr. George logo, Cancer Commons logo, and photo of John H. Strickler, MD, Associate Professor of Medicine, Division

Curious Dr. George—How an Expert Would Manage His Own Stage 4 Pancreatic Cancer: An Update

February 21, 2024

Here’s the latest from our Curious Dr. George! Read “How an Expert Would Manage His Own Stage 4 Pancreatic Cancer: An Update” here. When confronted with a new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Previously, our Curious Dr. George asked John H. Strickler, MD, how he would handle his own hypothetical diagnosis of metastatic pancreatic cancer. Now, Dr.… Read more »

Curious Dr. George logo, Cancer Commons logo, and photo of Al B. Benson III, MD, FACP, FACCC, FASCO

Curious Dr. George—How a Northwestern Professor Would Manage His Own Liver Cancer

February 13, 2024

Here’s the latest from our Curious Dr. George! Read “How Would a Northwestern Professor Manage His Own Liver Cancer?” here. hen facing a frightening new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks liver cancer expert Al B. Benson III, MD, FACP, FACCC, FASCO, how he would handle his own hypothetical… Read more »

Curious Dr. George logo over Cancer Commons logo, with photo of sphygmomanometer and photo of Robert E. Matthews, President and CEO of MediSync (Cincinnati)

Curious Dr. George—Successful Control of High Blood Pressure, a Major Cancer Comorbidity

December 7, 2023

Here’s the latest from our Curious Dr. George! Read “Successful Control of High Blood Pressure, a Major Cancer Comorbidity” here. People with cancer often face additional health conditions, or “comorbidities,” that complicate treatment. High blood pressure, or hypertension, is a major comorbidity that affects many cancer patients. Our Curious Dr. George asks Robert E. Matthews, President and CEO of MediSync (Cincinnati), about how his… Read more »

Curious Dr. George logo, Cancer Commons logo, photo of Stuart L. Marcus, MD, PhD, Founder & Chief Science Officer, SonALAsense

Curious Dr. George—High-Energy Blue Light Powers a Promising New Treatment to Destroy Cancer Cells

November 21, 2023

Here’s the latest from our Curious Dr. George! Read “High-Energy Blue Light Powers a Promising New Treatment to Destroy Cancer Cells” here. A perennial challenge in cancer treatment is figuring out how to kill tumor cells while leaving healthy cells unharmed. Our Curious Dr. George asks Stuart L. Marcus, MD, PhD, founder and Chief Science Officer at SonALAsense, how his company’s light-activated drug treatment addresses… Read more »

Curious Dr. George logo, Cancer Commons logo, photo of Miriam Chickering, RN, BSN, NE-BC, CEO of NextGenU.org

Curious Dr. George—Integrating AI-Generated Learning Materials into Health Professional Education

November 17, 2023

Here’s the latest from our Curious Dr. George! Read “Integrating AI-Generated Learning Materials into Health Professional Education” here. Artificial intelligence (A.I.) is a powerful tool that has made its way into diverse fields—and medical education is no exception. Our Curious Dr. George asks Miriam Chickering, RN, BSN, NE-BC, CEO of NextGenU.org, how the 22-year-old, U.S.-based organization she leads uses A.I. to help create free… Read more »